ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Polypeptide Drug Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-33V1528
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Polypeptide Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Polypeptide Drug Market Research Report 2025

Code: QYRE-Auto-33V1528
Report
August 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
Astrazeneca plc
SciClone Pharmaceuticals
Takeda
Roche
Sanofi

Polypeptide Drug Market Size

The global market for Polypeptide Drug was valued at US$ 756 million in the year 2024 and is projected to reach a revised size of US$ 1160 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Polypeptide Drug Market

Polypeptide Drug Market

Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polypeptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polypeptide Drug.
The Polypeptide Drug market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polypeptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polypeptide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Polypeptide Drug Market Report

Report Metric Details
Report Name Polypeptide Drug Market
Accounted market size in year US$ 756 million
Forecasted market size in 2031 US$ 1160 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Immunity Regulating Medicine (Allergy Infection and Immune)
  • Digestive System Drugs (Gastrointestinal Type)
  • Bone and Connective Tissue Types (Thyroid hormones Drug)
  • Gynecologic or Obstetric Drug
  • Tumor Drug
  • Urinary System Drug
  • Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Merck Serono, Ferring Pharmaceuticals, Ipsen PHarma Biotech, Lilly, Asahi Kasei, AstraZeneca, SciClone Pharmaceuticals, Takeda, Roche, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Polypeptide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Polypeptide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Polypeptide Drug Market growing?

Ans: The Polypeptide Drug Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Polypeptide Drug Market size in 2031?

Ans: The Polypeptide Drug Market size in 2031 will be US$ 1160 million.

Who are the main players in the Polypeptide Drug Market report?

Ans: The main players in the Polypeptide Drug Market are Novartis, Merck Serono, Ferring Pharmaceuticals, Ipsen PHarma Biotech, Lilly, Asahi Kasei, AstraZeneca, SciClone Pharmaceuticals, Takeda, Roche, Sanofi

What are the Application segmentation covered in the Polypeptide Drug Market report?

Ans: The Applications covered in the Polypeptide Drug Market report are Immunity Regulating Medicine (Allergy Infection and Immune), Digestive System Drugs (Gastrointestinal Type), Bone and Connective Tissue Types (Thyroid hormones Drug), Gynecologic or Obstetric Drug, Tumor Drug, Urinary System Drug, Metabolic Drug (Insulin and Other Hypoglycemic Agents)

What are the Type segmentation covered in the Polypeptide Drug Market report?

Ans: The Types covered in the Polypeptide Drug Market report are Injection, Nasal Administration, Lung Administration, Oral Administration, Transdermal Administration

Recommended Reports

Peptide and Protein Drugs

Disease Therapeutics

Drug Delivery & Diagnostics

1 Polypeptide Drug Market Overview
1.1 Product Definition
1.2 Polypeptide Drug by Type
1.2.1 Global Polypeptide Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Nasal Administration
1.2.4 Lung Administration
1.2.5 Oral Administration
1.2.6 Transdermal Administration
1.3 Polypeptide Drug by Application
1.3.1 Global Polypeptide Drug Market Value by Application (2024 VS 2031)
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug
1.3.7 Urinary System Drug
1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Global Polypeptide Drug Market Size Estimates and Forecasts
1.4.1 Global Polypeptide Drug Revenue 2020-2031
1.4.2 Global Polypeptide Drug Sales 2020-2031
1.4.3 Global Polypeptide Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Polypeptide Drug Market Competition by Manufacturers
2.1 Global Polypeptide Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Polypeptide Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Polypeptide Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Polypeptide Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polypeptide Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polypeptide Drug, Product Type & Application
2.7 Global Key Manufacturers of Polypeptide Drug, Date of Enter into This Industry
2.8 Global Polypeptide Drug Market Competitive Situation and Trends
2.8.1 Global Polypeptide Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Polypeptide Drug Players Market Share by Revenue
2.8.3 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polypeptide Drug Market Scenario by Region
3.1 Global Polypeptide Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Polypeptide Drug Sales by Region: 2020-2031
3.2.1 Global Polypeptide Drug Sales by Region: 2020-2025
3.2.2 Global Polypeptide Drug Sales by Region: 2026-2031
3.3 Global Polypeptide Drug Revenue by Region: 2020-2031
3.3.1 Global Polypeptide Drug Revenue by Region: 2020-2025
3.3.2 Global Polypeptide Drug Revenue by Region: 2026-2031
3.4 North America Polypeptide Drug Market Facts & Figures by Country
3.4.1 North America Polypeptide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Polypeptide Drug Sales by Country (2020-2031)
3.4.3 North America Polypeptide Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polypeptide Drug Market Facts & Figures by Country
3.5.1 Europe Polypeptide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Polypeptide Drug Sales by Country (2020-2031)
3.5.3 Europe Polypeptide Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polypeptide Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Polypeptide Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Polypeptide Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Polypeptide Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Polypeptide Drug Market Facts & Figures by Country
3.7.1 Latin America Polypeptide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Polypeptide Drug Sales by Country (2020-2031)
3.7.3 Latin America Polypeptide Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polypeptide Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Polypeptide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Polypeptide Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Polypeptide Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polypeptide Drug Sales by Type (2020-2031)
4.1.1 Global Polypeptide Drug Sales by Type (2020-2025)
4.1.2 Global Polypeptide Drug Sales by Type (2026-2031)
4.1.3 Global Polypeptide Drug Sales Market Share by Type (2020-2031)
4.2 Global Polypeptide Drug Revenue by Type (2020-2031)
4.2.1 Global Polypeptide Drug Revenue by Type (2020-2025)
4.2.2 Global Polypeptide Drug Revenue by Type (2026-2031)
4.2.3 Global Polypeptide Drug Revenue Market Share by Type (2020-2031)
4.3 Global Polypeptide Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Polypeptide Drug Sales by Application (2020-2031)
5.1.1 Global Polypeptide Drug Sales by Application (2020-2025)
5.1.2 Global Polypeptide Drug Sales by Application (2026-2031)
5.1.3 Global Polypeptide Drug Sales Market Share by Application (2020-2031)
5.2 Global Polypeptide Drug Revenue by Application (2020-2031)
5.2.1 Global Polypeptide Drug Revenue by Application (2020-2025)
5.2.2 Global Polypeptide Drug Revenue by Application (2026-2031)
5.2.3 Global Polypeptide Drug Revenue Market Share by Application (2020-2031)
5.3 Global Polypeptide Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Polypeptide Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Merck Serono
6.2.1 Merck Serono Company Information
6.2.2 Merck Serono Description and Business Overview
6.2.3 Merck Serono Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Serono Polypeptide Drug Product Portfolio
6.2.5 Merck Serono Recent Developments/Updates
6.3 Ferring Pharmaceuticals
6.3.1 Ferring Pharmaceuticals Company Information
6.3.2 Ferring Pharmaceuticals Description and Business Overview
6.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ferring Pharmaceuticals Polypeptide Drug Product Portfolio
6.3.5 Ferring Pharmaceuticals Recent Developments/Updates
6.4 Ipsen PHarma Biotech
6.4.1 Ipsen PHarma Biotech Company Information
6.4.2 Ipsen PHarma Biotech Description and Business Overview
6.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ipsen PHarma Biotech Polypeptide Drug Product Portfolio
6.4.5 Ipsen PHarma Biotech Recent Developments/Updates
6.5 Lilly
6.5.1 Lilly Company Information
6.5.2 Lilly Description and Business Overview
6.5.3 Lilly Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lilly Polypeptide Drug Product Portfolio
6.5.5 Lilly Recent Developments/Updates
6.6 Asahi Kasei
6.6.1 Asahi Kasei Company Information
6.6.2 Asahi Kasei Description and Business Overview
6.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Asahi Kasei Polypeptide Drug Product Portfolio
6.6.5 Asahi Kasei Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Polypeptide Drug Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 SciClone Pharmaceuticals
6.8.1 SciClone Pharmaceuticals Company Information
6.8.2 SciClone Pharmaceuticals Description and Business Overview
6.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 SciClone Pharmaceuticals Polypeptide Drug Product Portfolio
6.8.5 SciClone Pharmaceuticals Recent Developments/Updates
6.9 Takeda
6.9.1 Takeda Company Information
6.9.2 Takeda Description and Business Overview
6.9.3 Takeda Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Takeda Polypeptide Drug Product Portfolio
6.9.5 Takeda Recent Developments/Updates
6.10 Roche
6.10.1 Roche Company Information
6.10.2 Roche Description and Business Overview
6.10.3 Roche Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Roche Polypeptide Drug Product Portfolio
6.10.5 Roche Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Polypeptide Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Polypeptide Drug Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polypeptide Drug Industry Chain Analysis
7.2 Polypeptide Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polypeptide Drug Production Mode & Process Analysis
7.4 Polypeptide Drug Sales and Marketing
7.4.1 Polypeptide Drug Sales Channels
7.4.2 Polypeptide Drug Distributors
7.5 Polypeptide Drug Customer Analysis
8 Polypeptide Drug Market Dynamics
8.1 Polypeptide Drug Industry Trends
8.2 Polypeptide Drug Market Drivers
8.3 Polypeptide Drug Market Challenges
8.4 Polypeptide Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
Astrazeneca plc
SciClone Pharmaceuticals
Takeda
Roche
Sanofi
List of Tables
 Table 1. Global Polypeptide Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Polypeptide Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Polypeptide Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Polypeptide Drug Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Polypeptide Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Polypeptide Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Polypeptide Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Polypeptide Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Polypeptide Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Polypeptide Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Polypeptide Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Polypeptide Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Polypeptide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polypeptide Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Polypeptide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Polypeptide Drug Sales by Region (2020-2025) & (MT)
 Table 18. Global Polypeptide Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Polypeptide Drug Sales by Region (2026-2031) & (MT)
 Table 20. Global Polypeptide Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Polypeptide Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Polypeptide Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Polypeptide Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Polypeptide Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Polypeptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Polypeptide Drug Sales by Country (2020-2025) & (MT)
 Table 27. North America Polypeptide Drug Sales by Country (2026-2031) & (MT)
 Table 28. North America Polypeptide Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Polypeptide Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Polypeptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Polypeptide Drug Sales by Country (2020-2025) & (MT)
 Table 32. Europe Polypeptide Drug Sales by Country (2026-2031) & (MT)
 Table 33. Europe Polypeptide Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Polypeptide Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Polypeptide Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Polypeptide Drug Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Polypeptide Drug Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Polypeptide Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Polypeptide Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Polypeptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Polypeptide Drug Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Polypeptide Drug Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Polypeptide Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Polypeptide Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Polypeptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Polypeptide Drug Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Polypeptide Drug Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Polypeptide Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Polypeptide Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Polypeptide Drug Sales (MT) by Type (2020-2025)
 Table 51. Global Polypeptide Drug Sales (MT) by Type (2026-2031)
 Table 52. Global Polypeptide Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Polypeptide Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Polypeptide Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Polypeptide Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Polypeptide Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Polypeptide Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Polypeptide Drug Price (USD/MT) by Type (2020-2025)
 Table 59. Global Polypeptide Drug Price (USD/MT) by Type (2026-2031)
 Table 60. Global Polypeptide Drug Sales (MT) by Application (2020-2025)
 Table 61. Global Polypeptide Drug Sales (MT) by Application (2026-2031)
 Table 62. Global Polypeptide Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Polypeptide Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Polypeptide Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Polypeptide Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Polypeptide Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Polypeptide Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Polypeptide Drug Price (USD/MT) by Application (2020-2025)
 Table 69. Global Polypeptide Drug Price (USD/MT) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Novartis Polypeptide Drug Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Merck Serono Company Information
 Table 76. Merck Serono Description and Business Overview
 Table 77. Merck Serono Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Merck Serono Polypeptide Drug Product
 Table 79. Merck Serono Recent Developments/Updates
 Table 80. Ferring Pharmaceuticals Company Information
 Table 81. Ferring Pharmaceuticals Description and Business Overview
 Table 82. Ferring Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Ferring Pharmaceuticals Polypeptide Drug Product
 Table 84. Ferring Pharmaceuticals Recent Developments/Updates
 Table 85. Ipsen PHarma Biotech Company Information
 Table 86. Ipsen PHarma Biotech Description and Business Overview
 Table 87. Ipsen PHarma Biotech Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Ipsen PHarma Biotech Polypeptide Drug Product
 Table 89. Ipsen PHarma Biotech Recent Developments/Updates
 Table 90. Lilly Company Information
 Table 91. Lilly Description and Business Overview
 Table 92. Lilly Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Lilly Polypeptide Drug Product
 Table 94. Lilly Recent Developments/Updates
 Table 95. Asahi Kasei Company Information
 Table 96. Asahi Kasei Description and Business Overview
 Table 97. Asahi Kasei Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Asahi Kasei Polypeptide Drug Product
 Table 99. Asahi Kasei Recent Developments/Updates
 Table 100. AstraZeneca Company Information
 Table 101. AstraZeneca Description and Business Overview
 Table 102. AstraZeneca Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. AstraZeneca Polypeptide Drug Product
 Table 104. AstraZeneca Recent Developments/Updates
 Table 105. SciClone Pharmaceuticals Company Information
 Table 106. SciClone Pharmaceuticals Description and Business Overview
 Table 107. SciClone Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. SciClone Pharmaceuticals Polypeptide Drug Product
 Table 109. SciClone Pharmaceuticals Recent Developments/Updates
 Table 110. Takeda Company Information
 Table 111. Takeda Description and Business Overview
 Table 112. Takeda Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Takeda Polypeptide Drug Product
 Table 114. Takeda Recent Developments/Updates
 Table 115. Roche Company Information
 Table 116. Roche Description and Business Overview
 Table 117. Roche Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Roche Polypeptide Drug Product
 Table 119. Roche Recent Developments/Updates
 Table 120. Sanofi Company Information
 Table 121. Sanofi Description and Business Overview
 Table 122. Sanofi Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Sanofi Polypeptide Drug Product
 Table 124. Sanofi Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Polypeptide Drug Distributors List
 Table 128. Polypeptide Drug Customers List
 Table 129. Polypeptide Drug Market Trends
 Table 130. Polypeptide Drug Market Drivers
 Table 131. Polypeptide Drug Market Challenges
 Table 132. Polypeptide Drug Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Polypeptide Drug
 Figure 2. Global Polypeptide Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Polypeptide Drug Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Nasal Administration Product Picture
 Figure 6. Lung Administration Product Picture
 Figure 7. Oral Administration Product Picture
 Figure 8. Transdermal Administration Product Picture
 Figure 9. Global Polypeptide Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Polypeptide Drug Market Share by Application: 2024 & 2031
 Figure 11. Immunity Regulating Medicine (Allergy Infection and Immune)
 Figure 12. Digestive System Drugs (Gastrointestinal Type)
 Figure 13. Bone and Connective Tissue Types (Thyroid hormones Drug)
 Figure 14. Gynecologic or Obstetric Drug
 Figure 15. Tumor Drug
 Figure 16. Urinary System Drug
 Figure 17. Metabolic Drug (Insulin and Other Hypoglycemic Agents)
 Figure 18. Global Polypeptide Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Polypeptide Drug Market Size (2020-2031) & (US$ Million)
 Figure 20. Global Polypeptide Drug Sales (2020-2031) & (MT)
 Figure 21. Global Polypeptide Drug Average Price (USD/MT) & (2020-2031)
 Figure 22. Polypeptide Drug Report Years Considered
 Figure 23. Polypeptide Drug Sales Share by Manufacturers in 2024
 Figure 24. Global Polypeptide Drug Revenue Share by Manufacturers in 2024
 Figure 25. Global 5 and 10 Largest Polypeptide Drug Players: Market Share by Revenue in Polypeptide Drug in 2024
 Figure 26. Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Global Polypeptide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 28. North America Polypeptide Drug Sales Market Share by Country (2020-2031)
 Figure 29. North America Polypeptide Drug Revenue Market Share by Country (2020-2031)
 Figure 30. U.S. Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Canada Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Europe Polypeptide Drug Sales Market Share by Country (2020-2031)
 Figure 33. Europe Polypeptide Drug Revenue Market Share by Country (2020-2031)
 Figure 34. Germany Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. France Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. U.K. Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Italy Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Russia Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Asia Pacific Polypeptide Drug Sales Market Share by Region (2020-2031)
 Figure 40. Asia Pacific Polypeptide Drug Revenue Market Share by Region (2020-2031)
 Figure 41. China Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Japan Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. South Korea Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. India Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Australia Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. China Taiwan Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Indonesia Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Thailand Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Malaysia Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Polypeptide Drug Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Polypeptide Drug Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Polypeptide Drug Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Polypeptide Drug Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Polypeptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Polypeptide Drug by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Polypeptide Drug by Type (2020-2031)
 Figure 62. Global Polypeptide Drug Price (USD/MT) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Polypeptide Drug by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Polypeptide Drug by Application (2020-2031)
 Figure 65. Global Polypeptide Drug Price (USD/MT) by Application (2020-2031)
 Figure 66. Polypeptide Drug Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Polymixin B Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Colistin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Polymyxin E Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthesis Polypeptide Drugs Market Insights Forecast to 2030
Global Polypeptide Vaccine Market Research Report 2024
Global Glycopeptide Antibiotics Market Research Report 2024
Global Colistin Sulphate Market Insights Forecast to 2030
Global Polymixin Market Insights Forecast to 2030
Global Colistin Sulfate Market Research Report 2024
Global Oral Proteins and Peptides Market Research Report 2025
Global Chemosynthetic Polypeptide Drugs Market Research Report 2024
Global Polyoxin Market Insights Forecast to 2030
Global Chloramphenicol Antibiotics Market Research Report 2024
Peptide Antibiotics Sterile Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibacterial Active Peptide Market Research Report 2025
Antitumor Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lincomycin Antibiotics Market Research Report 2024
Therapeutic Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aminoglycosides Antibiotics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibiotics Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions